14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2014:T173309.20140117|
|Date of decision:||17 January 2014|
|Case number:||T 1733/09|
|IPC class:||A61K 51/10
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||METHOD FOR TREATING ORGANS AND TISSUES|
|Applicant name:||Immunomedics, Inc.|
|Opponent name:||Bayer Pharma Aktiengesellschaft|
|Relevant legal provisions:||
|Keywords:||Lapse of patent in all desginated states - (yes)
Patent proprietor sole appellant
Termination of appeal proceedings
Summary of Facts and Submissions
I. The patent proprietor (appellant) lodged an appeal against the decision of the opposition division taken at the oral proceedings dated 17 April 2009 , whereby European patent No. 0 637 933, which had been granted on the basis of European application No. 93 908 607.0, was revoked.
II. With a letter dated 21 June 2013, the appellant noted that the patent was not longer in force, since it expired in all remaining designated states at the end of its 20 year term. The appellant considered that there was no need to continue the appeal proceedings and requested the Board to terminate the proceedings under Rule 84(1) EPC.
III. By a communication dated 20 September 2013, the Board inter alia requested the parties to reconsider their requests for Oral Proceedings.
IV. In reply to the Board's communication, the respondent informed the Board and the appellant that it agreed with the Proprietor's statements and requests in its letter of 21 June 2013, including that the oral proceedings should be cancelled and the appeal proceedings terminated; the opposition division's decision would become final and the patent revoked.
V. With a letter dated 8 October 2013, the appellant informed the board and the respondent that it had no objection to the Board terminating the proceedings. The appellant withdrew its request for oral proceedings.
Reasons for the Decision
1. Pursuant to Article 63(1) EPC, the term of an European patent is 20 years from the date of filing of the application. Thus, the opposed patent has lapsed in all designated Contracting States. If a
European patent has lapsed in all designated States,
opposition proceedings may be continued at the request
of the opponent according to Rule 84(1) EPC.
2. According to Rule 100(1) EPC, this also applies in appeal proceedings following opposition proceedings. However, if, as in the present case, the patent proprietor is the sole appellant, it would be inappropriate to allow the opponent-respondent
to decide whether the appeal proceedings shall be
continued, so that it is the patent proprietor who can
request that the appeal proceedings be continued (see
3. As the appellant (patent proprietor) requested with letter dated 21 June 2013 to terminate the present appeal proceedings in accordance to Rule 84(1) EPC, the appeal proceedings are to be terminated.
For these reasons it is decided that:
The appeal proceedings are terminated.